Medirom Healthcare Technologies (NASDAQ:MRM) Trading Down 8.4% – Time to Sell?

Shares of Medirom Healthcare Technologies Inc. (NASDAQ:MRMGet Free Report) dropped 8.4% during trading on Thursday . The company traded as low as $1.50 and last traded at $1.53. Approximately 65,198 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 182,452 shares. The stock had previously closed at $1.67.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Medirom Healthcare Technologies in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

View Our Latest Research Report on MRM

Medirom Healthcare Technologies Stock Down 3.3%

The company has a quick ratio of 0.21, a current ratio of 0.24 and a debt-to-equity ratio of 2.42. The firm’s 50 day moving average price is $1.94.

Medirom Healthcare Technologies (NASDAQ:MRMGet Free Report) last released its quarterly earnings data on Tuesday, October 21st. The company reported ($0.30) earnings per share (EPS) for the quarter. The business had revenue of $11.28 million for the quarter.

About Medirom Healthcare Technologies

(Get Free Report)

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

Read More

Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.